Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Gonnesse, France Clinical Trials

A listing of Gonnesse, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (12) clinical trials

Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)

Multiple sclerosis (MS) usually evolves over decades and can present several phenotypes. Approximately 85% of newly diagnosed Multiple Sclerosis (MS) patients present the Relapsing-Remitting MS (RRMS) phenotype. After a mean time of approximatively 20 years, a large majority of these patients evolve to the so-called "Secondary Progressive MS" (SPMS) phase. …

Phase

0.0 miles

Learn More »

Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus

Prospective, multicenter, superiority, randomised, double blind study with two arms. In the 11 participating centers (9 in France and 2 in Belgium): selection of women with GDM between 12 and 34 weeks of gestation Explanation of protocol, with signature of consent in case of acceptation. Randomization Experimental group: The women …

Phase N/A

5.43 miles

Learn More »

OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome

The investigators make the hypothesis that an early outpatient treatment of COVID among patient with respiratory symptoms and risk factors for poor outcome can improve the prognosis of these patient and decrease the need for hospital admission. Our study is an open label randomized clinical trial comparing 4 arms of …

Phase

5.43 miles

Learn More »

COVID-19: Respiratory and Sleep Follow-up

Europe and in particular Italy, Spain and France are currently affected by the coronavirus 2019-nCoV pandemic, whose immediate prognosis is linked to the development of acute respiratory distress syndrome (ARDS). Beyond the long-term adverse effects on respiratory health and reduced exercise capacity, other complications will occur. These include a more …

Phase N/A

5.43 miles

Learn More »

Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents

In patients treated for exudative age-related macular degeneration (AMD), diabetes, retinal venous occlusion (OVR), or other conditions causing macular edema, treatments with anti-angiogenic intravitreal injections (IVT) are widely used both for their anti-angiogenic action. Patients often have injections for many years, sometimes monthly or every 2 months. The discontinuation of …

Phase N/A

7.21 miles

Learn More »

Imaging SARS-CoV-2 Involvement of Leptomeninges Olfactory and Limbic Areas

When patients arrive in the waiting room of the MRI department, patients will be given the briefing note explaining the purpose of the study and how it is going. During the consultation, the radiologist will check the inclusion and non-inclusion criteria, and will take the time to answer all of …

Phase N/A

7.21 miles

Learn More »

FURosemide Stress Test to Predict Need of Renal Replacement THERapy in Ischemic Acute Tubular Necrosis in ICU

FURTHER will enroll consecutive patients with AKI KDIGO stage 1 or 2 associated with a sepsis or following a cardiac surgery with CPB within 72h. Patients must have achieved a hemodynamic stabilization confirmed by clinical (no need for intravenous fluids, no significant variation of noradrenaline) and non-clinical (trans-thoracic echocardiography, passive …

Phase

7.91 miles

Learn More »

CPX-351 in Higher Risk Myelodysplastic Syndromes

A phase I/II study of the efficacy of CPX-351 treatment in patients with higher risk myelodysplastic syndromes : as first line treatment or after hypomethylating agents failure. CPX-351 is an advanced liposomal formulation of daunorubicin and cytarabine encapsulated at a 1:5 ratio. Patients will receive induction treatment with CPX-351. Patients …

Phase

8.49 miles

Learn More »

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

Phase

10.01 miles

Learn More »

Evaluation of New Biomarkers of Thrombosis in Myeloproliferative Neoplasms

Myeloproliferative neoplasms (MPN) are acquired clonal hematopoietic stem cell disorders, characterized by an increase in one or more myeloid lineages. The Philadelphia chromosome negative (Ph-) MPN include polycythemia vera (PV) with an excess of red blood cells, essential thrombocythemia (ET) with an increase in platelets and primary myelofibrosis (PMF). Arterial …

Phase N/A

10.01 miles

Learn More »